Health
Annovis Bio CEO to Present at Meridian Clinical Trials Summit
BERWYN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its Founder and more...
Biotech
ERYTECH Secures Euro10 Million in Non-Dilutive Financing, Guaranteed by the French Government
Approvals received from Bpifrance and Société Générale for a total of EUR 10 million in non-dilutive financing in the form of a State- Guarantee d Loan (PGE Loan) Proceeds expected to extend Company’s cash horizon more...
Biotech
NOVEMBER 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Fennec Pharmaceuticals Inc. (“Fennec” or “the Company”) more...
Mining
5 Top Weekly TSX Stocks: Alamos Gold Up on Quarterly Results
The S&P/TSX Composite Index (INDEXTSI: OSPTX ) trended down last week, closing at 15,591.53. The index was pushed lower on Friday (October 30) by energy stocks as an increase in coronavirus cases impacted investor sentiment. more...
Cannabis
Cannabis Weekly Round-Up: Village Farms Gets LP Ownership Deal
A Canadian cannabis company is celebrating a decision that will allow it to take full control of a third-party producer. Also in the market this week, two companies confirmed their merger and told shareholders the more...
Health
EVOLUS SHAREHOLDER NOTICE
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolus To Contact Him Directly To Discuss Their Options New York, New York–(Newsfile Corp. – November 1, 2020) – If you suffered more...